Wearables

Abbott Inks deal with Omada Health to integrate FreeStyle Libre with Omada’s Health coaching platform

Image: Abbott (PR Newswire photo)

Abbott has signed a partnership deal with Omada Health to integrate its FreeStyle Libre system with Omada Health’s pioneering digital care program. Freestyle Libre is Abbott’s revolutionary continuous glucose monitoring (CGM) technology. With this partnership the companies aim to create a new paradigm for people with Type 2 diabetes. The integrated solution with Omada will provide real-time glucose data and actionable information for participants to better manage their diabetes and guide personalized recommendations from their coaches, says a press release.

Eligible users with Type 2 diabetes will have the choice to integrate data from their FreeStyle Libre, including glucose reading, trends and patterns, with Omada’s platform. Following enrollment into the program, users can access a virtual physician, who can prescribe them the CGM.

More than 30 million Americans are living with diabetes. Among these individuals, roughly 95% are living with Type 2 diabetes1. Many are looking for simple ways to better manage their condition and overall health.

Image: Abbott (PR Newswire photo)

“The mission of Omada Health has always been to empower meaningful, sustainable behavior change for those individuals living with Type 2 diabetes and other chronic conditions,” said Omada co-founder and chief executive officer Sean Duffy. “Partnering with Abbott to give individuals access to FreeStyle Libre as part of the Omada program will deliver a unique combination of personalized human coaching and technology-enabled care to support those goals.”

Users need to use their smartphone for a one-second scan over the FreeStyle Libre sensor worn on the back of the upper arm to receive real-time glucose readings every minute, historical trends and patterns, and arrows showing where glucose levels are going.

“We’ve seen how FreeStyle Libre transforms lives through its proven track record in improving health outcomes, and our goal is to find new ways for even more people with diabetes to benefit from this technology,” said Jared Watkin, senior vice president, Diabetes Care, Abbott. “Through this collaboration, we’re creating a personalized care experience that combines Abbott’s leading CGM technology with Omada Health’s professional coaching and digital platform – giving people with Type 2 diabetes actionable information that leads to better health.”

Omada Health will offer the integrated solution to employers and health plans.

Source: www.wearable-technologies.com

 

Related posts

Maxim’s health sensors are ultra-small, use low power and deliver clinical-grade accuracy for next-gen wearables

Bodyelectron.com

No wires, more cuddles: Sensors are first to monitor babies in the NICU without wires

Bodyelectron.com

Analyzing sweat to diagnose diseases with a bandage-like biosensor

Bodyelectron.com